Cleared Traditional

.016' X .016 NICKEL TITANIUM UPRIGHTING SPRING (K923836) - FDA 510(k) Clearance

Class I Dental device.

K923836 · Ultimate Wireforms, Inc. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1992
Decision
146d
Days
Class 1
Risk

K923836 is an FDA 510(k) clearance for the .016' X .016 NICKEL TITANIUM UPRIGHTING SPRING. Classified as Wire, Orthodontic (product code DZC), Class I - General Controls.

Submitted by Ultimate Wireforms, Inc. (Terryville, US). The FDA issued a Cleared decision on December 23, 1992 after a review of 146 days - within the typical 510(k) review window.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.5410 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Ultimate Wireforms, Inc. devices

Submission Details

510(k) Number K923836 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 30, 1992
Decision Date December 23, 1992
Days to Decision 146 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 127d · This submission: 146d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code DZC Wire, Orthodontic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 872.5410
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.